Pro-Dex Inc
NASDAQ:PDEX

Watchlist Manager
Pro-Dex Inc Logo
Pro-Dex Inc
NASDAQ:PDEX
Watchlist
Price: 46.19 USD -2.28% Market Closed
Market Cap: 150.6m USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Pro-Dex Inc

Revenue
64.1m USD
Cost of Revenue
-44m USD
Gross Profit
20.1m USD
Operating Expenses
-8.4m USD
Operating Income
11.7m USD
Other Expenses
-2.3m USD
Net Income
9.4m USD

Margins Comparison
Pro-Dex Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Pro-Dex Inc
NASDAQ:PDEX
150.6m USD
31%
18%
15%
US
Abbott Laboratories
NYSE:ABT
215.2B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
185.9B USD
67%
28%
28%
US
Boston Scientific Corp
NYSE:BSX
153.3B USD
69%
19%
12%
US
Stryker Corp
NYSE:SYK
148.8B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
114.9B USD
66%
20%
14%
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
51.3B USD
45%
13%
7%
US
Edwards Lifesciences Corp
NYSE:EW
45B USD
79%
28%
75%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.5B USD
61%
29%
23%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
273.2B CNY
61%
34%
31%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Pro-Dex Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Pro-Dex Inc
NASDAQ:PDEX
150.6m USD
28%
16%
27%
20%
US
Abbott Laboratories
NYSE:ABT
215.2B USD
32%
18%
12%
21%
US
Intuitive Surgical Inc
NASDAQ:ISRG
185.9B USD
16%
14%
15%
18%
US
Boston Scientific Corp
NYSE:BSX
153.3B USD
10%
5%
10%
8%
US
Stryker Corp
NYSE:SYK
148.8B USD
14%
7%
15%
11%
IE
Medtronic PLC
NYSE:MDT
114.9B USD
9%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR
11%
4%
9%
6%
US
Becton Dickinson and Co
NYSE:BDX
51.3B USD
6%
3%
6%
5%
US
Edwards Lifesciences Corp
NYSE:EW
45B USD
49%
37%
15%
18%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.5B USD
59%
27%
51%
32%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
273.2B CNY
31%
21%
28%
34%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less